https://www.youtube.com/watch?v=WZk9BpO5xUI
Lung cancer clinical trial participant, Sheena, discusses what she would share with other Black Americans newly diagnosed with lung cancer.Support for this p

https://blackdoctor.org/stage-4-lung-cancer-why-i-said-yes-to-a-clinical-trial/
In March 2020, Sheena P. was diagnosed with stage 4 lung cancer, which came as a huge shock to her and her family. She decided to participate in a clinical trial based on a recommendation from her oncologist. When they performed a PET scan, they identified the area where her stage 4 lung cancer was located.

https://www.youtube.com/watch?v=N3RD4sxdMG4
Sheena, a lung cancer clinical trial participant, shares her decision to participate in a clinical trial.Support for this project made possible in part by Br

https://www.prnewswire.com/news-releases/new-campaign-strives-to-increase-access-to-lifesaving-lung-cancer-clinical-trials-for-black-americans-301472192.html
"This disease poses a risk to women, and African Americans are woefully underrepresented in clinical trials," said Sheena Payne, lung cancer clinical trial participant. "I think it is important to

https://www.lung.org/media/press-releases/lifesaving-lung-cancer-clinical-trials
Sometimes the most appropriate treatment option for a lung cancer patient is through a clinical trial. "This disease poses a risk to women, and African Americans are woefully underrepresented in clinical trials," said Sheena Payne, lung cancer clinical trial participant.

https://www.lung.org/blog/cancer-clinical-trials-diversity
Cancer is an area with a lot of room for improvement. Encouraging diversity in lung cancer clinical trials is an important part of working towards health equity.". Through her participation in a clinical trial, Sheena now takes a pill once a day which keeps her cancer under control. The clinical trial is highly monitored, and Sheena is in

https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/basics/lung-cancer-research/clinical-trials-black-americans
Lung cancer clinical trial participant, Sheena, discusses what she would share with other Black Americans newly diagnosed with lung cancer. ... Sometimes the most appropriate treatment option for a lung cancer patient is a clinical trial. Facts about Lung Cancer Clinical Trials. Clinical trials are highly monitored research studies. They can

https://www.clinicaldiversitysolutions.com/post/clinical-trial-participant-stories
Explore the videos below to hear stories from African-American clinical trial participants about how participating in a clinical trial saved their life. Sheena: Lung Cancer Clinical Trial Participant (American Lung Association) James P. Ross, Jr. (VCU Massey) Women in Clinical Trials: Juliana's Story (NIH) Christele's Story: Lupus and Clinical Trials (FDA) Preston's Story (Greater Gift

https://www.pacancercoalition.org/images/pdf/clinical_trials/Cancer_Clinical_Trials_Collaborative_Resources_for_Healthcare_Profession_to_Increase_Referrals_Access_to_and_Participation_in_Cancer_Clinical_Trials.pdf
Improving Lung Cancer Clinical Trial Enrollment in Black Americans. The Black community is ... • Dr. Ozuru Ukoha on Clinical Trials (30s) • Sheena on Clinical Trials (30s) ... • Sheena: Lung Cancer Clinical Trial Participant (1:49) • A Doctor and Pastor on Clinical Trials in the Black Community (1:53) Title: RCIs Collaborative to

https://respiratory-therapy.com/products-treatment/industry-regulatory-news/association-news/increasing-lung-cancer-clinical-trial-access-for-black-americans/
Each participant in a clinical trial is treated with the highest level of care. Sometimes the most appropriate treatment option for a lung cancer patient is through a clinical trial. ... and African Americans are woefully underrepresented in clinical trials," said Sheena Payne, lung cancer clinical trial participant. "I think it is

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440837/
The purpose of our study was to determine the historical trends and current landscape of reporting and representation of females and minorities in lung cancer phase III clinical trials. We chose to study lung cancer phase III clinical trials because lung cancer is the most common cause of cancer‐related death and manifests differently

https://classic.clinicaltrials.gov/ct2/show/NCT04497584
Chemotherapy, radiotherapy, or other cancer therapy within two weeks prior to starting study treatment. Subjects must have recovered from prior treatment-related to toxicities to grade 1 or baseline (excluding alopecia and clinically stable toxicities requiring ongoing medical management, such as hypothyroidism from prior immune checkpoint

https://www.verywellhealth.com/lung-cancer-clinical-trials-5271557
Clinical trials for lung cancer are an option for many people. If you're interested in participating in a clinical trial, talk to your healthcare provider. Search for a clinical trial that fits your specific cancer type and stage. Apply to the trial, and you'll be enrolled after pretrial testing and informed consent.

https://www.medscape.com/viewarticle/new-trials-lung-cancer-could-your-patients-benefit-2024a1000bo9
Several new lung cancer clinical trials have started recruiting — perhaps one of your patients can benefit? ... During dose optimization, each participant will take one of two oral doses of

https://utswmed.org/doctors/sheena-bhalla/
at Cancer Care Outpatient Building 6202 Harry Hines Blvd., 9th Floor. Dallas, Texas 75235 (214) 645-4673 Directions Parking Info. New Patient Appointment Accepting Virtual Visits or 214-645-4673. Sheena Bhalla, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center; she specializes in lung cancer.

https://www.survivornet.com/articles/mother-67-diagnosed-with-stage-4-lung-cancer-thriving-eight-years-later-with-new-targeted-medication/
Finding Hope In Clinical Trials. Colleen Conner Ziegler was diagnosed with stage 4 lung cancer in 2015. She's since participated in a clinical trial using a targeted therapy that's exceeded expectations for lung cancer with the ALK gene mutation. Five percent of non-small cell lung cancer (NSCLC) patients are caused by ALK gene mutation.

https://www.lungcancer.net.my/patient-article-sheena/
Lung Cancer Public Forum; FREE LDCT Lung Screening Programme; Hope For Survival Campaign; New Normal Same Cancer Campaign; Knowing Lung Cancer - 2021; Events-2021; Events-2020; Events-2019; CLINICAL TRIALS. Non-Small Cell Lung Carcinoma (NSCLC) Clinical Trials In Malaysia; Webcasts. TikTok Videos; Webcasts-2023; Webcasts-2022; Webcasts-2021

https://cancercommons.org/patient-story/sheena-advocates-for-the-best-possible-care-for-her-mothers-glioblastoma/
The family began looking into other treatment options for Shobha. "Every night, we researched clinical trials on ClinicalTrials.gov, and called the medical centers with trials in the morning," Sheena says. Meanwhile, they sought guidance from ASK Cancer Commons' Emma Shtivelman and from previously featured Super Advocate Stephen Western

https://ncbi.nlm.nih.gov/pmc/articles/PMC10015251/
Introduction. Lung cancer is one of the most typically diagnosed cancers and is responsible for approximately 20% of all cancer-related deaths across the globe. 1 Reducing the population burden of lung cancer is a high-priority action area for several health systems and screening techniques such as low-dose computed tomography (LDCT) are increasingly being used to detect early-stage lung

https://ichgcp.net/clinical-trials-registry/NCT06474611
Clinical Trial NCT06474611; Evaluation of a Patient 'Nudge' on Engagement in Lung Cancer Screening June 20, 2024 updated by: Debra Ritzwoller, ... In support of KP's Population Health priority initiative to expand lung cancer screening participation for those who are eligible, our study team was selected to move this work forward in 2024 with

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243778/
Females have historically been underrepresented in biomedical research, including oncology clinical trials. 1-3 In 2002, a widely cited study found that females comprised only 34.7% of participants in cancer prevention and treatment trials from 1990 to 2001. 4 A 2013 updated study revealed continued sex gaps from 2000 to 2010. 5 The persistent

https://ichgcp.net/clinical-trials-registry/NCT06479473
Clinical Trial NCT06479473; Radiotherapy to All Residual Lesions After Chemoimmunotherapy June 24, 2024 updated by: Dong Qian, Anhui Provincial Hospital. ... Extensive-stage small-cell lung cancer is a lethal malignancy with an extremely poor prognosis. First-line chemotherapy could only achieve an overall survival of approximately 10 months.

https://ichgcp.net/clinical-trials-registry/NCT06480734
The present prospective study investigates, whether the results of the previous prospective trial can be generalized to elderly patients aged ≥65 years. Its major goal is the identification of the optimal cut-off score to correctly diagnose pneumonitis and discriminate it from other lung diseases in elderly patients irradiated for lung cancer.

https://www.mdpi.com/2076-393X/12/7/713
In patients with lung cancer (LC), understanding factors that impact the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike antibody (SAb) titers over time is critical, but challenging, due to evolving treatments, infections, vaccinations, and health status. The objective was to develop a time-dependent regression model elucidating individual contributions of